René G. Ott

2.4k total citations
15 papers, 931 citations indexed

About

René G. Ott is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, René G. Ott has authored 15 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Genetics. Recurrent topics in René G. Ott's work include Fungal and yeast genetics research (3 papers), Immune Cell Function and Interaction (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). René G. Ott is often cited by papers focused on Fungal and yeast genetics research (3 papers), Immune Cell Function and Interaction (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). René G. Ott collaborates with scholars based in Austria, United States and Switzerland. René G. Ott's co-authors include Jeffrey V. Ravetch, Veronika Sexl, K. Dane Wittrup, Stephen L. Sazinsky, Bruce Tidor, Eva Weisz, Michael Freissmuth, Richard Moriggl, Hugo Mouquet and Patrick C. Wilson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

René G. Ott

15 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
René G. Ott Austria	10	457	367	247	190	163	15	931
Irene Leung United States	13	625 1.4×	444 1.2×	621 2.5×	252 1.3×	70 0.4×	30	1.2k
Emil H. Palacios United States	7	319 0.7×	659 1.8×	80 0.3×	224 1.2×	147 0.9×	8	994
Gabriele Beck‐Engeser United States	19	465 1.0×	563 1.5×	210 0.9×	151 0.8×	44 0.3×	31	1.0k
Nicole Brass Germany	15	566 1.2×	468 1.3×	116 0.5×	346 1.8×	52 0.3×	20	1.0k
Sophie Lebel‐Binay France	17	343 0.8×	435 1.2×	65 0.3×	279 1.5×	84 0.5×	21	977
Keisuke Horikawa Australia	16	320 0.7×	908 2.5×	165 0.7×	188 1.0×	31 0.2×	28	1.3k
Daniel B. Rubinstein United States	13	350 0.8×	296 0.8×	142 0.6×	159 0.8×	26 0.2×	20	753
A C Bloem Netherlands	18	517 1.1×	532 1.4×	132 0.5×	363 1.9×	86 0.5×	34	1.4k
Mitchell E. Reff United States	21	781 1.7×	387 1.1×	555 2.2×	159 0.8×	34 0.2×	41	1.2k
A. Miyajima Japan	14	348 0.8×	452 1.2×	100 0.4×	223 1.2×	29 0.2×	27	992

Countries citing papers authored by René G. Ott

Since Specialization

Citations

This map shows the geographic impact of René G. Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René G. Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René G. Ott more than expected).

Fields of papers citing papers by René G. Ott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René G. Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René G. Ott. The network helps show where René G. Ott may publish in the future.

Co-authorship network of co-authors of René G. Ott

This figure shows the co-authorship network connecting the top 25 collaborators of René G. Ott. A scholar is included among the top collaborators of René G. Ott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René G. Ott. René G. Ott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Addeo, Alfredo, Maximilian J. Hochmair, Elizabeth Dudnik, et al.. (2021). Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT). Therapeutic Advances in Medical Oncology. 13. 4277471906–4277471906. 6 indexed citations

Ott, René G., et al.. (2020). TORC1 ensures membrane trafficking of Tat2 tryptophan permease via a novel transcriptional activator Vhr2 in budding yeast. Cellular Signalling. 68. 109542–109542. 3 indexed citations

Addeo, Alfredo, Maximilian J. Hochmair, Elizabeth Dudnik, et al.. (2020). 1299P Real-world treatment patterns, clinical outcomes and EGFR/T790M testing practices in patients with EGFRm advanced NSCLC and 1L EGFR TKI therapy: A retrospective multinational study (REFLECT). Annals of Oncology. 31. S840–S840. 1 indexed citations

Thallinger, Christiane, Tanja Čufer, Jacek Jassem, et al.. (2020). Limitations of cancer care in Central and South-Eastern Europe: results of the international conference organized by the Central European Cooperative Oncology Group (CECOG). Journal of Health Inequalities. 6(2). 139–152. 9 indexed citations

Kollmann, Karoline, Gerwin Heller, René G. Ott, et al.. (2011). c-JUN promotes BCR-ABL–induced lymphoid leukemia by inhibiting methylation of the 5′ region of Cdk6. Blood. 117(15). 4065–4075. 27 indexed citations

Mouquet, Hugo, Johannes F. Scheid, Marie Zöller, et al.. (2010). Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature. 467(7315). 591–595. 318 indexed citations

Sazinsky, Stephen L., et al.. (2008). Aglycosylated immunoglobulin G₁variants productively engage activating Fc receptors. Proceedings of the National Academy of Sciences. 105(51). 20167–20172. 132 indexed citations

Mayerhofer, Matthias, Karoline V. Gleixner, Gregor Hoermann, et al.. (2007). Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib. Blood. 111(4). 2200–2210. 78 indexed citations

Ott, René G., Olivia Simma, Karoline Kollmann, et al.. (2007). JunB is a gatekeeper for B-lymphoid leukemia. Oncogene. 26(33). 4863–4871. 19 indexed citations

10.

Staber, Philipp B., Paul Vesely, René G. Ott, et al.. (2007). The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling. Blood. 110(9). 3374–3383. 79 indexed citations

11.

Kovačic, Boris, Dagmar Stoiber, Richard Moriggl, et al.. (2006). STAT1 acts as a tumor promoter for leukemia development. Cancer Cell. 10(1). 77–87. 127 indexed citations

12.

Ott, René G., Karin Athenstaedt, Claudia Hrastnik, et al.. (2005). Flux of sterol intermediates in a yeast strain deleted of the lanosterol C-14 demethylase Erg11p. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1735(2). 111–118. 22 indexed citations

13.

Kenner, Lukas, Eva Weisz, René G. Ott, et al.. (2003). JunB inhibits proliferation and transformation in B-lymphoid cells. Blood. 102(12). 4159–4165. 68 indexed citations

14.

Mo, Caiqing, Paola Milla, Karin Athenstaedt, et al.. (2003). In yeast sterol biosynthesis the 3-keto reductase protein (Erg27p) is required for oxidosqualene cyclase (Erg7p) activity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1633(1). 68–74. 38 indexed citations

15.

Ott, René G., et al.. (1986). Bremen im Dritten Reich : Anpassung, Widerstand, Verfolgung. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact